Heart disease has long been framed through a single, dramatic lens: a sudden block in a major artery causing crushing chest pain. Yet, millions of women experience heart disease through an entirely different and far more insidious pathway. Coronary Microvascular Disease (CMD), or microvascular angina, affects the microscopic blood vessels and capillaries supplying the heart muscle. Operating beneath the resolution of standard diagnostic tools, its symptoms are frequently misdiagnosed as anxiety, acid reflux, or stress.
To shed light on this critical women’s health issue, Indian cardiologists Dr. Vijay D’Silva, medical director at White Lotus International Hospital and clinical advisor and mentor at Heartnet India, alongside Dr. Anupama V Hegde, senior consultant in the department of cardiology at Ramaiah Memorial Hospital, Bengaluru, break down the mechanics, diagnostics, and treatment strategies of microvascular heart disease.
The paradox of atypical symptoms
Unlike localised blockages in major vessels that trigger sharp, central chest pressure, microvascular dysfunction starves the heart muscle of oxygen in a diffuse manner. Dr D’Silva outlines mechanical dysfunction in the microvasculature:1. Failure to dilate: The smallest heart vessels fail to expand or may even actively constrict when oxygen demand increases.2. Diffuse ischemia: Because oxygen depletion is spread across a network of tiny capillaries rather than confined to one large artery, pain does not present as classic focal chest pressure.3. Widespread discomfort: Abnormalities are present in the regulation of the small coronary arteries with regard to the blood flow to the heart muscles in microvascular angina. The small coronary arteries may not effectively dilate in response to the increased need for oxygen in the heart muscles, or they may actually cause constriction. Over time, this can lead to a reduction in blood flow to the heart muscles. Sometimes the ischemia is not localised, so the woman can’t feel the pain as chest pain. Instead, she has other sensations such as weakness and shortness of breath, abdominal pain, and sweating.
Structural anatomical differences in women
Female vascular anatomy fundamentally alters how cardiac ischemia presents during daily routines. Women naturally possess smaller coronary vessel diameters compared to men. Consequently, disease burden in female patients is more frequently concentrated in the smaller capillaries rather than the epicardial branches.
Dr Hegde emphasises that these structural nuances change how symptoms surface. He says, “Women frequently present with atypical symptoms. In fact, approximately 50 per cent experience non-traditional signs like excessive sweating, palpitations, breathlessness, profound fatigue, nausea, and vomiting. Compared to men, women have smaller coronary vessels, meaning the disease is more likely to affect the tiny capillaries rather than major arteries. These symptoms often surface during emotional stress or routine daily activities rather than classic chest pain during exertion, which is why key warning signs are so easily missed.”
Estrogen loss and endothelial impairment
The inner lining of blood vessels—the endothelium—relies heavily on estrogen to maintain vascular flexibility and nitric oxide-dependent vasodilation. During perimenopause and post menopause, declining estrogen levels compromise endothelial health, increasing vascular resistance and triggering alterations in blood pressure, lipid metabolism, and insulin sensitivity.
“Endothelial function in the coronary microvasculature plays an important role in heart function. Estrogen affects the vasculature through its ability to promote endothelial function and nitric oxide-dependent vasodilation. In the perimenopausal period, decreased levels of estrogen in the body are associated with alterations in blood pressure, lipid metabolism, insulin resistance, and vascular functions that increase the risk of development of coronary microvascular disease in females,” explains Dr D’Silva.
Inflammation and compounding risk factors
Systemic autoimmune conditions and chronic inflammation further jeopardise the microvasculature through oxidative stress and structural vessel damage. However, these factors act cumulatively alongside traditional metabolic risk factors like hypertension, diabetes, and hypercholesterolaemia.
“Chronic inflammation and autoimmune diseases can cause damage to the endothelium through inflammation and oxidative stress processes. However, inflammation and autoimmunity act as additional factors because menopause or autoimmune disease does not automatically mean the presence of the disease,” Dr D’Silva adds.
Dr Hegde notes that clinical risk compounds rapidly when hormonal shifts intersect with underlying health conditions. She says, “Women who are perimenopausal and postmenopausal, those with long-standing blood pressure or diabetes, uncontrolled cholesterol levels, or family history of heart problems in young tend to have small-vessel disease. The decline in estrogen contributes partially to these atypical symptoms, and traditional symptoms can occur if the patient has diabetes, long-standing hypertension, or is perimenopausal or postmenopausal.”
The diagnostic ‘blind spot’
There are limitations of standard testingConventional cardiac workups are designed to detect structural blockages in major arteries, leaving small-vessel issues invisible. Dr D’Silva breaks down this fundamental technological limitation:1. Angiogram limitations: Standard coronary angiograms evaluate only the large epicardial arteries, failing to assess microvascular perfusion.2. Stress test blind spots: Routine exercise stress tests look for reduced blood flow from single major blockages, missing widespread capillary dysfunction.3. False reassurance: Normal results on standard tests often lead clinicians to falsely rule out heart disease.4. The diagnostic gap: Distinguishing between large coronary arteries and smaller vessels is essential. While standard angiograms easily detect major artery blockages, they cannot evaluate how small vessels supply blood under stress. Conventional stress tests also focus on major obstructions, often yielding normal results despite microvascular dysfunction. Consequently, women frequently experience clear cardiac symptoms yet receive normal test results, creating a diagnostic gap that delays the recognition and treatment of microvascular disease.
Delayed care and diagnostic gaps
This technological limitation leaves many women stranded without a clear diagnosis or appropriate treatment plan. Standard invasive interventions, such as angioplasty with stenting or bypass surgery, are entirely ineffective for small-vessel dysfunction because there is no single physical blockage to open.
Dr Hegde confirms this diagnostic hurdle, “The routine ECG and echo sometimes may not pick up any ischemic signs. Most of the traditional treatment like thrombolysis or angioplasty with stenting or bypass surgeries are targeted at the major blood vessels, but the microvasculature or the smaller vessels like capillaries, these cannot be assessed adequately on the conventional angiogram.”
Advanced diagnostics and navigating clinical evaluations
Specialised functional diagnostic toolsWhen routine tests fail to yield answers, clinicians must turn to advanced physiological investigations designed to assess coronary flow reserve, vasomotion, and vascular resistance under stress.
Dr D’Silva details these specialised pathways, “As angiography is more focused on the structure of the epicardial coronary arteries, a normal angiogram does not rule out the possibility of the presence of coronary microvascular disease. However, in case of suspicion of this pathology, tests of physiological function of coronary circulation can be performed. PET myocardial perfusion imaging allows for assessment of coronary blood flow rate and coronary flow reserve, while stress cardiac MRI provides information on the myocardial perfusion in functional terms. There are also some invasive tests that allow for assessment of coronary flow reserve, resistance, and vasomotion. The choice of test should depend on the patient’s symptoms, history, and overall clinical picture rather than simply asking for a particular investigation.”
Dr Hegde highlights how functional exercise testing can offer an accessible preliminary screen, “When you do a treadmill test or a stress echo, the ischemic signs can be picked up. Special tests like cardiac MRI, stress MRI, PET scan are required to pick up the microvascular angina.”
Differentiating cardiac from non-cardiac conditions
During an emergency or primary care evaluation, distinguishing small-vessel disease from non-cardiac conditions requires evaluating the overall context of symptoms, risk profiles, and clinical history rather than relying on a single test.
“The focus should be firstly on the pattern and context of the symptoms rather than arriving at a diagnosis purely based on one symptom alone. Pain and breathlessness on exertion, stress, or increased demand on the heart; reduction in exercise tolerance unexpectedly; unexplained fatigue; and nausea, sweating, dizziness, and chest pain or jaw, back, or upper abdominal pain can suggest a cardiac problem. A lack of obstruction seen on angiography or unremarkable ECG findings do not automatically rule out a cardiac problem in this situation. In my clinical experience, this is when the necessity for a thorough cardiac evaluation emerges,” Dr D’Silva explains.
Tailored management and long-term care
Targeted pharmacological therapiesBecause stents and bypass surgery cannot open microscopic capillaries, medical management relies on drugs that optimise vessel function. Hegde outlines effective medical treatments: 1. Coronary vasodilators: Medications like nitroglycerin and ranolazine help dilate small blood vessels.2. Calcium channel blockers and beta-blockers: Regulate vascular tone, reduce vessel spasms, and lower cardiac oxygen demand.3. Preserving cardiac pumping function: Early medical management prevents long-term heart muscle strain.4. Medication strategies: Early treatment with medications such as calcium channel blockers, beta-blockers, or coronary vasodilators (like nitroglycerin and ranolazine) effectively manages microvascular angina by opening blood vessels. When caught and treated promptly, these therapies relieve symptoms, protect heart function, and enable patients to maintain a near-normal life.
Lifestyle interventions and vascular rehabilitationStructured lifestyle modifications are equally crucial. “Regular exercise acts as a non-pharmacological therapy by opening up dormant microvascular beds and improving collateral circulation,” says Dr Hegde. She emphasises the power of proactive lifestyle changes and patient self-advocacy:1. Weight management: Weight reduction is essential, as obesity contributes directly to microvascular issues. Reducing body weight diminishes systemic inflammation and vascular resistance.2. Capillary recruitment through exercise: Regular exercise forces naturally closed microvascular beds to open, improving collateral circulation. 3. Heart-healthy nutrition: Adopting a heart-healthy diet builds heart strength and opens dormant microvascular vessels to boost blood flow. Supports overall vascular compliance and metabolic control.4. Self-advocacy and early care: Women must never ignore atypical symptoms or assume estrogen offers full protection. It is strongly advisable to seek early medical evaluation if symptoms persist.
World Heart Day 2026: Health experts unmask microvascular heart disease in women
